Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

<< Previous

Bullboard Posts

Next >>

Post by Duster340on Jun 08, 2022 3:48pm

136 Views

Post# 34741465

The cpi #'s (inflation)

come out on friday. the last rate in the usa was 8.3% down from 8.5% in april. my guess we will see a new all time high on friday of. i will take a guess at it and say 8.6%+, mostly driven by the price of gas which is out of control. this # will spook the market, so i say big red day friday, the tech stocks will take a hit. also a possible recession coming before the end of the year. lots of fear in the market.

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program